Literature DB >> 9118531

Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine.

M Koide1, M Nagatsu, M R Zile, M Hamawaki, M M Swindle, G Keech, G DeFreyte, H Tagawa, G Cooper, B A Carabello.   

Abstract

BACKGROUND: When a pressure overload is placed on the left ventricle, some patients develop relatively modest hypertrophy whereas others develop extensive hypertrophy. Likewise, the occurrence of contractile dysfunction also is variable. The cause of this heterogeneity is not well understood. METHODS AND
RESULTS: We recently developed a model of gradual proximal aortic constriction in the adult canine that mimicked the heterogeneity of the hypertrophic response seen in humans. We hypothesized that differences in outcome were related to differences present before banding. Fifteen animals were studied initially. Ten developed left ventricular dysfunction (dys group). Five dogs maintained normal function (nl group). At baseline, the nl group had a lower mean systolic wall stress (96 +/- 9 kdyne/cm2; dys group, 156 +/- 7 kdyne/cm2; P < .0002) and greater relative left ventricular mass (left ventricular weight [g]/body wt [kg], 5.1 +/- 0.36; dys group, 3.9 +/- 0.26; P < .02). On the basis of differences in mean systolic wall stress at baseline, we predicted outcome in the next 28 dogs by using a cutoff of 115 kdyne/cm2. Eighteen of 20 dogs with baseline mean systolic stress > 115 kdyne/cm2 developed dysfunction whereas 6 of 8 dogs with resting stress < or = 115 kdyne/cm2 maintained normal function.
CONCLUSIONS: We conclude that this canine model mimicked the heterogeneous hypertrophic response seen in humans. In the group that eventually developed dysfunction there was less cardiac mass despite 60% higher wall stress at baseline, suggesting a different set point for regulating myocardial growth in the two groups.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Year:  1997        PMID: 9118531     DOI: 10.1161/01.cir.95.6.1601

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.

Authors:  K C Chang; V M Figueredo; J H Schreur; K Kariya; M W Weiner; P C Simpson; S A Camacho
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Coexisting cardiac diseases and pressure recovery phenomenon contribute to discrepancy between the echocardiographic severity of aortic stenosis and left ventricular hypertrophy.

Authors:  Ayumu Abe; Taisei Mikami; Sanae Kaga; Kanako Tsuji; Kazunori Okada; Shinobu Yokoyama; Hisao Nishino; Masahiro Nakabachi; Mutsumi Nishida; Chikara Shimizu; Hiroyuki Iwano; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  J Echocardiogr       Date:  2013-01-09

Review 3.  Cardiac microtubules in health and heart disease.

Authors:  Matthew A Caporizzo; Christina Yingxian Chen; Benjamin L Prosser
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-09

4.  SLIT3 deficiency attenuates pressure overload-induced cardiac fibrosis and remodeling.

Authors:  Lianghui Gong; Shuyun Wang; Li Shen; Catherine Liu; Mena Shenouda; Baolei Li; Xiaoxiao Liu; John A Shaw; Alan L Wineman; Yifeng Yang; Dingding Xiong; Anne Eichmann; Sylvia M Evans; Stephen J Weiss; Ming-Sing Si
Journal:  JCI Insight       Date:  2020-06-18

5.  In vivo measurements of the contributions of protein synthesis and protein degradation in regulating cardiac pressure overload hypertrophy in the mouse.

Authors:  Paul J McDermott; Catalin F Baicu; Shaun R Wahl; An O Van Laer; Michael R Zile
Journal:  Mol Cell Biochem       Date:  2012-05-19       Impact factor: 3.396

6.  Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.

Authors:  M Turcani; H Rupp
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 7.  Cardiocyte cytoskeleton in hypertrophied myocardium.

Authors:  G Cooper
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

8.  Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.

Authors:  Timothy D O'Connell; Philip M Swigart; M C Rodrigo; Shinji Ishizaka; Shuji Joho; Lynne Turnbull; Laurence H Tecott; Anthony J Baker; Elyse Foster; William Grossman; Paul C Simpson
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

9.  Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan.

Authors:  M Turcani; H Rupp
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 10.  Small and large animal models in cardiac contraction research: advantages and disadvantages.

Authors:  Nima Milani-Nejad; Paul M L Janssen
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.